BT
ABBV icon

Banque Transatlantique’s AbbVie ABBV Stock Holding History

Banque Transatlantique’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
5,858
+45
+0.8% +$9.68K 0.03% 138
2026
Q1 		$1.26M Buy
5,813
+5,005
+619% +$1.11M 0.03% 126
2025
Q4 		$184K Sell
808
-301
-27% -$68.6K ﹤0.01% 125
2025
Q3 		$257K Sell
1,109
-50
-4% -$10.2K 0.01% 110
2025
Q2 		$215K Sell
1,159
-41
-3% -$7.62K 0.01% 110
2025
Q1 		$251K Hold
1,200
– – 0.01% 109
2024
Q4 		$212K Buy
+1,200
New +$221K 0.01% 114

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Banque Transatlantique's ABBV Position: Q2 2026 in Review

Banque Transatlantique increased its AbbVie (ABBV) stake by 0.77% in Q2 2026, buying an estimated $9.68K and bringing the position to 5,858 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #138.

Banque Transatlantique first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Banque Transatlantique held 5,858 shares of AbbVie worth $1.47M as of Q2 2026.
  • Banque Transatlantique bought 45 AbbVie shares in Q2 2026, an estimated $9.68K.
  • AbbVie made up 0.03% of Banque Transatlantique's portfolio in Q2 2026, its #138 holding.
  • Banque Transatlantique first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.